Bivalirudin
9 FDA-DMF suppliersProtein
Overview
Bivalirudin is a protein active pharmaceutical ingredient (ChEMBL CHEMBL5314348).
API suppliers (9)
Suppliers of Bivalirudin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- BACHEM INCSwitzerland1 active DMF
- Dr. Reddy's Laboratories Ltd.India1 active DMF
- HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDChina1 active DMF
- Pharmaron Beijing Co., Ltd.China1 active DMF
- SCINOPHARM TAIWAN LTDTaiwan1 active DMF
- Shenzhen Salubris Pharmaceuticals Co., Ltd.China1 active DMF
- SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDChina1 active DMF
- Sun Pharmaceutical Industries LimitedIndia1 active DMF
- TAPI NL BVNetherlands1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (9 approved US products), the latest listed US patent on Bivalirudin expires 20 May 2039. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.